三生国健(688336)每日收评(04-01)

Group 1 - The stock of Sanofi (三生国健688336) has a comprehensive score of 60.82, indicating a strong performance [1] - The main cost analysis shows the current price at 29.23 CNY, with a 5-day cost of 27.83 CNY and a 20-day cost of 24.28 CNY [1][3] - There have been no instances of the stock hitting the upper or lower limits in the past year [1] Group 2 - The short-term resistance level is at 28.04 CNY, while the short-term support level is at 26.95 CNY [2] - The stock price has broken through the short-term resistance level, suggesting a potential short-term strength [2][3] - The K-line pattern indicates a "Red Three Soldiers" formation, suggesting a possible bottoming out and recovery [2][3] Group 3 - On April 1, 2025, the net inflow of main funds was 14.66 million CNY, accounting for 7% of the total transaction volume [2] - Large orders saw a net inflow of 18.18 million CNY, while super large orders experienced a net outflow of 3.52 million CNY [2][3] - Retail investors contributed a net inflow of 502,100 CNY [2] Group 4 - The latest financial data shows earnings per share at 0.38 CNY, with an operating profit of 262 million CNY [2] - The gross profit margin stands at 71.259%, with a net profit of 222.76 million CNY [2][3] - The stock is associated with sectors such as bioproducts (4.38%), monoclonal antibodies (4.73%), and recombinant proteins (5.50%) [2]